| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 41,354 | 39,406 | 41,957 | 39,629 | | Cost of Revenue | 20,173 | 19,250 | 19,517 | 18,197 | | | Gross Profit | 21,181 | 20,156 | 22,440 | 21,432 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,610 | 15,099 | 15,713 | 15,773 | | Non Recurring |
-
|
-
| 37,519 |
-
| | Others | 217 | 163 | 158 | 159 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,354 | 4,894 | (30,950) | 5,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (951) |
-
|
-
| | Earnings Before Interest And Taxes | 5,201 | 3,943 | (30,950) | 5,500 | | Interest Expense |
-
| (774) | 264 | 510 | | Income Before Tax | 5,201 | 4,717 | (31,214) | 4,990 | | Income Tax Expense | 2,010 | 1,698 | (7,855) | 1,878 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,191 | 3,019 | (23,359) | 3,112 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,191 | 3,019 | (23,359) | 3,112 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,191 | $3,019 | ($23,359) | $3,112 |
|
0.51% Nasdaq 
0.08 (0.64%) 
Income Statement
